Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
Real-world treatment patterns and outcomes of zanubrutinib in chronic lymphocytic leukemia and small lymphocytic leukemia (CLL/SLL). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting ...
The Horner–Wadsworth–Emmons (HWE) reaction is a fundamental reaction in organic chemistry, widely used to create conjugated carbonyl compounds. Conjugated carbonyl compounds are used in many ...
The National Institutes of Health (NIH) Center for Scientific Review has appointed Sukyung Woo, PhD, associate professor, Department of Pharmaceutical Sciences, to serve as a member of its Drug ...
SCOTTSDALE, Ariz. — Feb. 18, 2025 — Sunil Sharma, M.D., MBA, one of the nation’s leading experts in creating anti-cancer drugs, has been named director of HonorHealth Research Institute’s new Center ...
(Top) Melanoma develops resistance to BRAF inhibitors, leading to cancer recurrence. (Bottom) By combining polyamine biosynthesis inhibition with BRAF inhibitors, the recurrence of cancer can be ...
Pamela Goodwin has received hundreds of emails from patients asking if they should take a cheap, readily available drug, metformin, to treat their cancer. It’s a fair question: Metformin, commonly ...
Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results